MLP CARE Completed the Year With Growth Above Expectations in 2018
MLP CARE Completed the Year With Growth Above Expectations in 2018
PR77761
ISTANBUL, March 8, 2019 /PRNewswire=KYODO JBN/ --
MLP ("MLP Care") (BIST: MPARK), the leading private healthcare service
provider in Turkey, today announces its financial results for the full year
ended December 31, 2018.
(TL millon) 2018 2017 Change Q4 2018 Q4 2017 Change
Revenue 3,132 2,576 21.6% 880 703 25.3%
Comparable1 Revenue 3,045 2,576 18.2% 840 703 19.5%
Adj. EBITDA2 505 409 23.5% 152 126 20.3%
Adj. Margin (%) 16.1% 15.9% 25bps 17.3% 18.0% (71bps)
Comparable1 Adj.
EBITDA 530 409 29.7% 155 126 22.9%
Adj. Margin (%) 17.4% 15.9% 155bps 18.5% 18.0% 51bps
Adj. EBITDAR2 748 598 25.1% 215 176 22.2%
Adj. Margin (%) 23.9% 23.2% 68bps 24.4% 25.0% (62bps)
Net Profit/(Loss) (104) (133) (21.9%) 39 (60) (165.7%)
Net Profit/(Loss)
Normalized for
FX Losses (Including
Hedging Cost) 142 35 300.1% (1) 21 (102.5%)
1 Excluding the contribution from hospitals opened in 2018
2 Based on Reported EBITDA (Earnings Before Interest, Taxes, Depreciation,
Amortization) /EBITDAR (Earnings Before Interest, Taxes, Depreciation,
Amortization, Rent Expenses) adjusted for one-time (income) / expenses, net and
non-cash GAAP provision expenses
Financial Highlights
- In Q4 2018, revenues increased to TL880 million, up by 25.3% vs. Q4 2017.
Revenues in 2018 were TL3,132 million, up by 21.6% vs. last year (2017: TL2,576
million). When revenues of managed hospitals were included, revenue growth in
Q4 2018 was 29.1% and in 2018 was 27.7%.
- Adj. EBITDA increased by 20.3% in Q4 2018, bringing 2018 EBITDA growth to
23.5% vs. last year.
- When normalized for the negative EBITDA contribution from hospitals
opened in 2018, comparable EBITDA growth was 22.9% in Q4 2018 and 29.7% in
2018.
- In 4Q 2018, a net profit of TL39 million was recorded due to strong
operational performance, lower financial expenses and FX losses.
- A net loss of TL104 million was recorded in 2018 due to the TL245 million
of FX losses from the hard currency denominated debt (2017: Net loss: TL133
million, FX losses: TL168 million). Net profit normalized for FX losses
increased from TL35 million in 2017 to TL142 million in 2018.
- The net debt/Adj. EBITDA ratio declined to 2.5x at the end of 2018
compared to 3.4x a year ago.
Operating Highlights
- The ramp up of the new hospitals opened in 2018 is on track.
- Continued focus on maintaining strong growth in medical tourism (11% of
in total revenues in 2018 vs. 7% last year).
- All of the FX denominated hospital building lease agreements converted to
TL as of October 2018.
- Efficiency initiatives in place to improve margins.
Dr. Muharrem Usta, Chairman and Chief Executive Officer of MLP Care,
commented:
"We are very pleased to complete 2018 with delivering operational results
above expectations and fulfilling promises given to investors during the
initial public offering.
"We have focused on the successful ramp up of the two new hospitals opened
in 2018 as well as operational improvements to increase patient satisfaction
and effective cost management across all our hospitals. Our foreign medical
tourism revenues maintained its high growth momentum in 2018. In the last
quarter of 2018, we posted net profit thanks to continued growth in EBITDA and
appreciation of TL.
"We, as MLP Care, will continue to focus on initiatives for further
operational efficiency and to create value for our patients and stakeholders as
well as our country."
ENQUIRIES
For financial reports and further information regarding MLP Care, please
visit our website at http://investor.mlpcare.com/en or you may contact:
Dr. Deniz Can Yuecel
Strategy and Investor Relations Director
T +90 212 227 5555 (Ext: 1148)
E deniz.yucel@mlpcare.com
Logo - https://mma.prnewswire.com/media/832651/MLP_Care_Logo.jpg
Source: MLP CARE
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。